Source: International Congress 2014 – Latest insights in airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Dicpinigaitis, S. Dhar, A. Johnson, Y. Gayle, J. Brew, W. Caparros-Wanderley (Bronx, United States Of America; London, United Kingdom). LATE-BREAKING ABSTRACT: Antitussive effect of a diphenhydramine-containing multicomponent cough syrup in acute viral cough.. Eur Respir J 2014; 44: Suppl. 58, 2812

Member's Comments

No comment yet.

Related content which might interest you: Pharmacology of cough Source: Annual Congress 2008 - MP15 - Pharmacology of cough Year: 2008 Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 LATE-BREAKING ABSTRACT: Tackling the burden of chronic cough: A dose escalation study of AF-219 Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: Observational study on effectiveness of the combination of antitussives and NASAIDs in patients with URTI related cough Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 LATE-BREAKING ABSTRACT: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Antibiotic or symptomatic therapy in URTI-related pediatric acute cough? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 H4 receptor antagonits as a potential medication for upper airway cough syndrom Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Codeine for treatment of cough variant asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: the SIRIUS study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Assessment of cough frequency to inhaled mannitol using ambulatory acoustic cough recording Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Treatment of chronic cough with morphine Source: Eur Respir J 2006; 28: Suppl. 50, 437s Year: 2006 Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 LATE-BREAKING ABSTRACT: Attenuation of allergen-induced asthmatic responses by inhaled GATA-3 specific DNAzyme Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Effect of aclidinium/formoterol fixed-dose combinations on respiratory symptoms in COPD patients Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Effect of tiotropium on cough reflex sensitivity in acute viral cough Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 The inverse agonist propranolol does not confer steroid-sparing activity in persistent asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 The effect of twice-daily aclidinium bromide on cough and sputum in patients with COPD: Results from phase III studies Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014